[1] Cooperative Group for Hepatic and Gall Diseases. Expert consensus on diagnosis and treatment of pyrrolidine alkaloids - related sinusoidal obstruction syndrome (2017,Nanjing)[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2017, 33(9): 1627-1637. [2] YU LC, MAO YM, CHEN CW.Guidelines for diagnosis and treatment of drug-induced liver injury[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2015, 31(11): 1752-1769. [3] Branch of Hepatobiliary Diseases China Association of Chinese Medicine, Branch of Chinese Patent Medicine China Association of Chinese Medicine. Guideline for diagnosis and treatment of herb-induced liver injury[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2016, 32(5): 835-843. [4] YIN LS, LI XY, SUN R.Analysis of the causes of senecio scandens clinical adverse reactions[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(3): 160-163. [5] FENG Q, LI XY, SUN R.Advance research on pharmacological effect and toxicity of senecio scandens[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2014, 11(3): 151-153. [6] ZHU CK, ZHANG F, ZHUGE YZ, et al.Clinical characteristics of 115 cases of gynura segetum induced hepatic sinusoidal obstruction syndrome[J]. Chinese Journal of Digestion(中华消化杂志), 2017, 37(7): 448-452. [7] YAKUSHIJIN K, ATSUTA Y, DOKI N, et al.Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes[J]. Bone Marrow Transplant, 2016, 51(3): 403-409. [8] LIU F, CAO X, YE J, et al.Oxaliplatin-induced hepatic sinusoidal obstruction syndrome in a patient with gastric cancer: a case report[J]. Mol Clin Oncol, 2018, 8(3): 453-456. [9] SHEN T, FENG XW, GENG L, et al.Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation[J]. World J Gastroenterol, 2015, 21(20): 6422-6426. [10] ZHUGE YZ, WANG Y, ZHANG F, et al.Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease[J]. Liver Int, 2018, 38(10): 1867-1874. [11] WANG JY, GAO H.Tusanqi and hepatic sinusoidal obstruction syndrome[J]. J Dig Dis, 2014, 15(3): 105-107. [12] LIN G, WANG JY, LI N, et al.Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum[J]. J Hepatol, 2011, 54(4): 666-673. [13] YANG XQ, YE J, LI X, et al.Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes[J]. World J Gastroenterol, 2019, 25(28): 3753-3763. [14] MOHTY M, MALARD F, ABECASSIS M, et al.Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)[J]. Bone Marrow Transplant, 2015, 50(6): 781-789. [15] ZHANG YT, LI S, ZHOU DH, et al.Clinical features of sinusoidal obstruction syndrome: an analysis of 35 cases and literature review[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2013, 29(12): 936-939. [16] ZHU H, CHU Y, HUO J, et al.Effect of prednisone on transforming growth factor-β1, connective tissue growth factor, nuclear factor-κBp65 and tumor necrosis factor-α expression in a murine model of hepatic sinusoidal obstruction syndrome induced by Gynura segetum[J]. Hepatol Res, 2011, 41(8): 795-803. [17] VALLA DC.Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome[J]. Gut, 2008, 57(10): 1469-1478. [18] DIGNAN FL, WYNN RF, HADZIC N, et al.BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation[J]. Br J Haematol, 2013, 163(4): 444-457. [19] ZHU L, ZHANG CY, LI DP, et al.Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China[J]. Acta Pharmacol Sin, 2021, 42(8): 1212-1222. [20] KAKAR F, AKBARIAN Z, LESLIE T, et al.An outbreak of hepatic veno-occlusive disease in western Afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids[J]. J Toxicol, 2010(7980): 313280. [21] EDGAR JA, SMITH LW.Transfer of pyrrolizidine alkaloids into eggs: food safety implications[J]. ACS Symp Ser, 1999, 745: 118-128. [22] KEMPF M, HEIL S, HASSLAUER I, et al.Pyrrolizidine alkaloids in pollen and pollen products[J]. Mol Nutr Food Res, 2010, 54(2): 292-300. [23] PANTER KE, JAMES LF.Natural plant toxicants in milk: a review[J]. J Anim Sci, 1990, 68(3): 892-904. |